background image
Life sciences

Building Africa’s Precision Medicine Future

Africa's role in global health has long been underestimated— but that's changing. We're laying the foundation for world-class precision medicine research across the continent by enabling advanced sequencing infrastructure, connecting local sites and healthcare providers, and fostering collaboration from grassroots to global networks.

Life Science Hero Image
Shooting Arrows

Why Africa?

African populations exhibit a greater number of genetic variants, reflecting their status as the oldest lineage of modern humans.

In contrast, non-African populations have experienced genetic drift and founder effects, resulting in reduced genetic diversity over time.

This variant diversity can lead to...

Better Disease Risk Assessment

A wider range of genetic variants means more accurate identification of hereditary disease risks, including cancer, cardiovascular disorders, and neurological conditions

Improved Drug Response Predictions

Africa's diverse genomic landscape offers valuable insights for optimizing treatments for African patients and others worldwide who share unique genetic variants, leading to fewer adverse drug reactions and improved therapeutic efficacy

Advancements in global medicine and discovery of novel therapeutic targets

Exploring African genetic diversity enhances global research by revealing new biological pathways and deepening our understanding of human evolution and disease mechanisms.

Africa by the numbers

Unlocking the future of global health, innovation, and human potential begins with understanding Africa.

54

Countries across the continent

1.5B

People living in Africa today

2,000+

Ethnolinguistic groups with rich cultural heritage

#3

Nigeria’s rank by population by 2050 (surpassing the U.S.)

1 in 4

People globally will be African by 2050

1M+

New cancer diagnoses annually (underreported)

Innovative Solutions for Future Ready Pharma and Biotech

We provide innovative solutions tailored for forward-thinking pharma and biotech companies, enabling them to stay ahead of the competition while ensuring their offerings are inclusive and accessible to all

We offer a comprehensive range of next-generation sequencing services, supporting both retrospective and prospective clinical studies as well as sponsored testing. Our goal is to identify patients best suited for targeted therapies, advancing precision medicine. By conducting sequencing in our state-of-the-art labs across Africa, we are committed to fostering inclusive science and ensuring equitable access to cutting-edge genetic analysis
Precision Logo

Looking to collaborate on your precision medicine studies?

Join our Precision54 Clinical Hub to access pre-qualified sites in Africa and significantly reduce your study startup times!

Precision Doctors